Literature DB >> 11443878

T-bodies as antiviral agents.

N Bitton1, P Debre, Z Eshhar, G Gorochov.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11443878     DOI: 10.1007/978-3-662-05783-4_14

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  4 in total

1.  Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.

Authors:  Li Liu; Bhavik Patel; Mustafa H Ghanem; Virgilio Bundoc; Zhili Zheng; Richard A Morgan; Steven A Rosenberg; Barna Dey; Edward A Berger
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

Review 2.  Quarter Century of Anti-HIV CAR T Cells.

Authors:  Thor A Wagner
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

3.  A Trispecific Anti-HIV Chimeric Antigen Receptor Containing the CCR5 N-Terminal Region.

Authors:  Agnes Hajduczki; David T Danielson; David S Elias; Virgilio Bundoc; Aaron W Scanlan; Edward A Berger
Journal:  Front Cell Infect Microbiol       Date:  2020-05-25       Impact factor: 5.293

4.  CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies.

Authors:  Annette Romanski; Christoph Uherek; Gesine Bug; Erhard Seifried; Hans Klingemann; Winfried S Wels; Oliver G Ottmann; Torsten Tonn
Journal:  J Cell Mol Med       Date:  2016-03-23       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.